相关实验视频

Updated: Jul 22, 2026

Protocols for Robust Herbicide Resistance Testing in Different Weed Species

Protocols for Robust Herbicide Resistance Testing in Different Weed Species

Published on: July 2, 2015

从使用小麦RIL种群的QTLs中识别Fusarium头炎耐药性的候选基因

Mingxia Zhang^1,2, Peng Jiang³, Qun Wu²

¹College of Plant Protection, Shandong Agricultural University, Tai'an, 271018, China.

Plant molecular biology

|May 21, 2024

概括

在小麦中研究了菌头炎 (FHB) 的耐药性,使用复合杂交品种. 研究人员在19个稳定的QTL中确定了36个候选基因,推动了开发抗病小麦品种的努力.

科学领域:

植物科学植物科学
遗传学遗传学是一个
农业科学农业科学

背景情况:

虫头炎 (Fusarium head blight,FHB) 是一种主要的小麦疾病,导致大量的产量和质量损失.
开发抗FHB的小麦品种对于粮食安全至关重要.

研究的目的:

为了确定与FHB耐药性相关的定量特征位点 (QTL) 和候选基因.
分析一组重组杂交系 (RILs) 的FHB耐药性.

主要方法:

在四个环境中的TL-RIL中对FHB耐药性的表型评估 (NDS和RDI).
建立一个基因图 (UG-Map) 并识别了19个稳定的QTLs.
在使用RefSeq v1.1基因组识别的QTL中进行候选基因分析.

主要成果:

在19个稳定的QTL中,发现了36个FHB耐药性候选基因 (NDS和RDI).
七个候选基因与小麦和相关物种中先前报告的FHB耐药基因具有同质性.
另外5个候选基因参与了植物对病原体的防御反应.

结论:

已识别的候选基因与小麦的FHB耐药性密切相关.
这项研究为培育FHB耐药小麦品种提供了宝贵的遗传资源.

关键词:

类头部病 (FHB) 是一种类头部病.候选基因是一个候选基因.定量的特征位置 (QTL)再组合的同血统 (RIL) 线.小麦小麦小麦小麦的小麦.

更多相关视频

Development of Targeting Induced Local Lesions IN Genomes TILLING Populations in Small Grain Crops by Ethyl Methanesulfonate Mutagenesis

Development of Targeting Induced Local Lesions IN Genomes TILLING Populations in Small Grain Crops by Ethyl Methanesulfonate Mutagenesis

Published on: July 16, 2019

Tomato Root Transformation Followed by Inoculation with Ralstonia Solanacearum for Straightforward Genetic Analysis of Bacterial Wilt Disease

Tomato Root Transformation Followed by Inoculation with Ralstonia Solanacearum for Straightforward Genetic Analysis of Bacterial Wilt Disease

Published on: March 11, 2020

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...